History
  • No items yet
midpage
CERx Pharmacy Partners, LP v. Provider Meds, LP (In re Providerx of Grapevine, LLC)
507 B.R. 132
| Bankr. N.D. Tex. | 2014
Read the full case

Background

  • CERx loaned about $8.92M to Provider Meds, LP under May 6, 2011 loan documents (PSA, Term Sheet, Convertible Note, Collateral Assignments).
  • PI assets pledged: Patent Applications and related IP; language in PSA and Term Sheet governing scope of security interests.
  • CERx filed a UCC-1 Financing Statement with Texas authorities describing Patent Applications; non-patent IP not clearly specified.
  • CERx issued a Transmittal Letter and a Notice of Disposition (Dec. 13, 2012) regarding disposition of collateral; sale conducted publicly.
  • CERx purchased PM’s IP Assets at the December 13, 2012 sale; PM’s bankruptcy petition followed; Trustees contested aspects.
  • Original Memorandum Opinion (Aug. 2, 2013) held non‑patent IP unperfected and subject to 544(a) avoidance; reconsideration granted on issues of notice scope and disposition.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Did PM grant CERx a security interest in all PM IP Assets? CERx argues broad grant under Term Sheet and PSA. PM/Trustees contend only Patent Applications were covered. Yes, as clarified on reconsideration.
Was CERx properly perfected in PM’s non-patent IP assets? CERx contends sufficient to perfect broader IP. UCC-1 limited to Patent Applications; non-patent IP not perfected. No; perfection limited to Patent Applications.
Was CERx's Notice of Disposition valid to support sale of IP assets? Notice together with Transmittal Letter gave actual notice. Notice deficiencies could affect damages but not void sale. Disposition valid; sale upheld.
Does the strong-arm power under 11 U.S.C. § 544 apply to the IP Assets? CERx’s prepetition sale should be avoided by trustee. Sale occurred prepetition; not a property of PM’s estate. Not availing strong-arm rights; sale not avoided.
Is the Source Code ownership issue (PM vs OnSiteRx) for trial? CERx contends PM owned Source Code; rights implicated. OnSiteRx ownership; disputes unresolved. Genuine issue of material fact remains for trial.

Key Cases Cited

  • Looney v. Nuss, 545 F.2d 916 (5th Cir.1977) (objective intent to grant security may be inferred from multiple documents)
  • Crow-Southland v. North Ft. Worth Bank., 838 S.W.2d 720 (Tex.App.-Dallas 1992) (collateral descriptions affect inquiry notice in financing statements)
  • In re Casbeer, 793 F.2d 1436 (5th Cir.1986) (strong-arm consideration in bankruptcy security interests)
  • Frost Nat’l Bank v. L & F Distribs., 165 S.W.3d 310 (Tex.2005) (contract interpretation—consider entire writing and business context)
Read the full case

Case Details

Case Name: CERx Pharmacy Partners, LP v. Provider Meds, LP (In re Providerx of Grapevine, LLC)
Court Name: United States Bankruptcy Court, N.D. Texas
Date Published: Mar 13, 2014
Citation: 507 B.R. 132
Docket Number: Bankruptcy No. 12-38039-BJH; Adversary No. 13-03015-BJH
Court Abbreviation: Bankr. N.D. Tex.